A citation-based method for searching scientific literature

Barbara M Norquist, Maria I Harrell, Mark F Brady, Tom Walsh, Ming K Lee, Suleyman Gulsuner, Sarah S Bernards, Silvia Casadei, Qian Yi, Robert A Burger, John K Chan, Susan A Davidson, Robert S Mannel, Paul A DiSilvestro, Heather A Lankes, Nilsa C Ramirez, Mary Claire King, Elizabeth M Swisher, Michael J Birrer. JAMA Oncol 2016
Times Cited: 331



Kathleen Moore, Nicoletta Colombo, Giovanni Scambia, Byoung-Gie Kim, Ana Oaknin, Michael Friedlander, Alla Lisyanskaya, Anne Floquet, Alexandra Leary, Gabe S Sonke, Charlie Gourley, Susana Banerjee, Amit Oza, Antonio González-Martín, Carol Aghajanian, William Bradley, Cara Mathews, Joyce Liu, Elizabeth S Lowe, Ralph Bloomfield, Paul DiSilvestro. N Engl J Med 2018
Times Cited: 696




List of shared articles



Times cited

Tumor and germline next generation sequencing in high grade serous cancer: experience from a large population-based testing program.
Melanie Care, Jeanna McCuaig, Blaise Clarke, Sylvie Grenier, Raymond H Kim, Marjan Rouzbahman, Natalie Stickle, Marcus Bernardini, Tracy L Stockley. Mol Oncol 2021
3

The current landscape of molecular profiling in the treatment of epithelial ovarian cancer.
Carolyn E Haunschild, Krishnansu S Tewari. Gynecol Oncol 2021
3

Impact of BRCA1/2 Mutations on the Efficacy of Secondary Cytoreductive Surgery.
Felipe Leonardo Estati, Rafaela Pirolli, Viviane Teixeira Loiola de Alencar, Adriana Regina Gonçalves Ribeiro, Maria Nirvana Formiga, Giovana Tardin Torrezan, Dirce Maria Carraro, Andrea Paiva Gadelha Guimarães, Glauco Baiocchi, Alexandre André Balieiro Anastácio da Costa. Ann Surg Oncol 2021
3

FLABRA, frontline approach for BRCA testing in an ovarian cancer population: a Latin America epidemiologic study.
Gonzalo Giornelli, Dolores Gallardo, Roberto Hegg, Gonzalo Gomez Abuin, Maximo De La Vega, Maria Lim-Law, Valeria Caceres, Lina Trujillo, Maria Del Pilar Estevez-Diz, Cristian Pacheco,[...]. Future Oncol 2021
0

The RAD51D c.82G>A (p.Val28Met) variant disrupts normal splicing and is associated with hereditary ovarian cancer.
Ciyu Yang, Angela G Arnold, Amanda Catchings, Vikas Rai, Zsofia K Stadler, Liying Zhang. Breast Cancer Res Treat 2021
0

Outcomes of incidentally detected ovarian cancers diagnosed at time of risk-reducing salpingo-oophorectomy in BRCA mutation carriers.
Renee Cowan, Silvana Pedra Nobre, Nisha Pradhan, Maya Yasukawa, Qin C Zhou, Alexia Iasonos, Robert A Soslow, Angela G Arnold, Magan Trottier, Amanda Catchings,[...]. Gynecol Oncol 2021
0

Management of the Elderly Patients with High-Grade Serous Ovarian Cancer in the REAL-WORLD Setting.
Michalis Liontos, Alkistis Papatheodoridi, Angeliki Andrikopoulou, Nikolaos Thomakos, Dimitrios Haidopoulos, Alexandros Rodolakis, Flora Zagouri, Aristotelis Bamias, Meletios-Athanasios Dimopoulos. Curr Oncol 2021
0

Precision medicine for hereditary tumors in gynecologic malignancies.
Masayuki Sekine, Takayuki Enomoto. J Obstet Gynaecol Res 2021
0

Plasma Protein Biomarkers Associated with Higher Ovarian Cancer Risk in BRCA1/2 Carriers.
Hee-Sung Ahn, Jung Yoon Ho, Jiyoung Yu, Jeonghun Yeom, Sanha Lee, Soo Young Hur, Yuyeon Jung, Kyunggon Kim, Youn Jin Choi. Cancers (Basel) 2021
0


Validation of BRCA testing on cytologic samples of high-grade serous carcinoma.
Si Kei Lou, Sylvie Grenier, Melanie Care, Jeanna McCuaig, Tracy L Stockley, Blaise Clarke, Heather M Ruff, Scott L Boerner. Cancer Cytopathol 2021
0

Reliability of Tumor Testing Compared to Germline Testing for Detecting BRCA1 and BRCA2 Mutations in Patients with Epithelial Ovarian Cancer.
Christine Bekos, Christoph Grimm, Marlene Kranawetter, Stephan Polterauer, Felicitas Oberndorfer, Yen Tan, Leonhard Müllauer, Christian F Singer. J Pers Med 2021
0

Epithelial ovarian cancer risk: A review of the current genetic landscape.
Nicola Flaum, Emma J Crosbie, Richard J Edmondson, Miriam J Smith, Dafydd G Evans. Clin Genet 2020
7

Exploring the Clinical Impact of Predictive Biomarkers in Serous Ovarian Carcinomas.
Cécile Le Page, Jacqueline Chung, Kurosh Rahimi, Martin Köbel, Diane Provencher, Anne-Marie Mes-Masson. Curr Drug Targets 2020
0

Current Approaches to Germline Cancer Genetic Testing.
Elena M Stoffel, John M Carethers. Annu Rev Med 2020
3

A phase 1 dose-escalation study of intraperitoneal cisplatin, intravenous/intraperitoneal paclitaxel, bevacizumab, and olaparib for newly diagnosed ovarian cancer.
Karen A Cadoo, Rachel N Grisham, Roisin E O'Cearbhaill, Nicole N Boucicaut, Melissa Henson, Alexia Iasonos, Qin Zhou, Debra M Sarasohn, Jacqueline Gallagher, Sara Kravetz,[...]. Gynecol Oncol 2020
1

Germline and Somatic Tumor Testing in Epithelial Ovarian Cancer: ASCO Guideline.
Panagiotis A Konstantinopoulos, Barbara Norquist, Christina Lacchetti, Deborah Armstrong, Rachel N Grisham, Paul J Goodfellow, Elise C Kohn, Douglas A Levine, Joyce F Liu, Karen H Lu,[...]. J Clin Oncol 2020
41

Genetic testing for epithelial ovarian cancer.
Noa Amin, Narda Chaabouni, Angela George. Best Pract Res Clin Obstet Gynaecol 2020
1

Pathologic findings and clinical outcomes in women undergoing risk-reducing surgery to prevent ovarian and fallopian tube carcinoma: A large prospective single institution experience.
Shannon K Rush, Elizabeth M Swisher, Rochelle L Garcia, Kathryn P Pennington, Kathy J Agnew, Mark R Kilgore, Barbara M Norquist. Gynecol Oncol 2020
2

Germline and Somatic BRCA1/2 Mutations in 172 Chinese Women With Epithelial Ovarian Cancer.
Yan You, Lei Li, Junliang Lu, Huanwen Wu, Jing Wang, Jie Gao, Ming Wu, Zhiyong Liang. Front Oncol 2020
4




Factors associated with referral and completion of genetic counseling in women with epithelial ovarian cancer.
Stephanie Alimena, Lauren Scarpetti, Erica L Blouch, Linda Rodgers, Kristen Shannon, Marcela Del Carmen, Annekathryn Goodman, Whitfield B Growdon, Eric Eisenhauer, Rachel Clark Sisodia. Int J Gynecol Cancer 2020
1

Setting a baseline: A 7-year review of referral rates and outcomes for serous ovarian cancer prior to implementation of oncologist mediated genetic testing.
Susan Randall Armel, Alexandra Volenik, Rochelle Demsky, Janet Malcolmson, Manjula Maganti, Jeanna McCuaig. Gynecol Oncol 2020
2

Emerging drugs for the treatment of ovarian cancer: a focused review of PARP inhibitors.
Elizabeth K Lee, Ursula A Matulonis. Expert Opin Emerg Drugs 2020
1


The Landscape and Therapeutic Implications of Molecular Profiles in Epithelial Ovarian Cancer.
Ludivine Dion, Isis Carton, Sylvie Jaillard, Krystel Nyangoh Timoh, Sébastien Henno, Hugo Sardain, Fabrice Foucher, Jean Levêque, Thibault de la Motte Rouge, Susie Brousse,[...]. J Clin Med 2020
3